Agoff SN, Swanson PE, Linden H, Hawes SE, Lawton TJ: Androgen receptor expression for the estrogen receptor-bad breast cancer
Bieche I, Parfait B, Tozlu S, Lidereau Roentgen, Vidaud Yards: Quantitation from androgen receptor gene term in sporadic breast tumors because of the real-date RT-PCR: proof one to MYC was a keen AR-controlled gene. Carcinogenesis. 2001, twenty-two (9): 1521-1526. /carcin/twenty two.9.1521.
Bratthauer GL, Lininger RA, Guy YG, Tavassoli FA: Androgen and you may the hormone estrogen receptor mRNA reputation inside the apocrine carcinomas. Diagn Mol Pathol. 2002, eleven (2): 113-118. 9606-200206000-00008.
Gatalica Z: Immunohistochemical data regarding apocrine breast lesions. Uniform over-expression out-of androgen receptor accompanied by the loss of estrogen and you may progesterone receptors in the apocrine metaplasia and you may apocrine carcinoma in situ. Pathol Res Pract. 1997, 193 (11-12): 753-758.
Are J Clin Pathol
Soreide JA, Lea OA, Varhaug JE, Skarstein An effective, Kvinnsland S: Androgen receptors inside the operable cancer of the breast: reference to most other steroid hormones receptors, correlations to prognostic items and you may predictive value to possess effect of adjuvant tamoxifen procedures. Eur J Surg Oncol. 1992, 18 (2): 112-118.
Bayer-Garner bu siteyi Ã§evir IB, Smoller B: Androgen receptors: an effective marker to increase awareness to have identifying breast cancer within the skin metastasis out-of not familiar pri, 13 (2): 119-122. /modpathol.3880021.
Nelson AR, Fingleton B, Rothenberg ML, Matrisian LM: Matrix metalloproteinases: biologic pastime and logical implications. J Clin Oncol. 2000, 18 (5): 1135-1149.
Pang ST, Flores-Morales A, Skoog L, Chuan YC, Nordstedt G, Pousette Good: Regulation out-of matrix metalloproteinase thirteen term of the androgen in the prostate cancers. Read more